Dawnrays Pharmaceutical (Holdings) Limited
HKSE 2348.HK
Dawnrays Pharmaceutical (Holdings) Limited Market Capitalization on January 14, 2025: USD 229.20 M
-
Dawnrays Pharmaceutical (Holdings) Limited 52-week high Market Capitalization is USD 268.46 M on October 07, 2024, which is 17.13% above the current Market Capitalization.
-
Dawnrays Pharmaceutical (Holdings) Limited 52-week low Market Capitalization is USD 192.38 M on January 22, 2024, which is -16.06% below the current Market Capitalization.
-
Dawnrays Pharmaceutical (Holdings) Limited average Market Capitalization for the last 52 weeks is USD 224.54 M.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Ms. Liwei Yu |
| IPO Date | July 11, 2003 |
| Location | Hong Kong |
| Headquarters | CNT Tower |
| Employees | 1,175 |
| Sector | Health Care |
| Industries | |
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Past 5 years
USD 0.56
USD 1.08
StockViz Staff
January 15, 2025
Any question? Send us an email